CDKN2B upregulation prevents teratoma formation in multipotent fibromodulin-reprogrammed cells

Tumorigenicity is a well-documented risk to overcome for pluripotent or multipotent cell applications in regenerative medicine. To address the emerging demand for safe cell sources in tissue regeneration, we established a novel, protein-based reprogramming method that does not require genome integra...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Invest
Main Authors: Zheng, Zhong, Li, Chenshuang, Ha, Pin, Chang, Grace X., Yang, Pu, Zhang, Xinli, Kim, Jong Kil, Jiang, Wenlu, Pang, Xiaoxiao, Berthiaume, Emily A., Mills, Zane, Haveles, Christos S., Chen, Eric, Ting, Kang, Soo, Chia
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6668700/
https://ncbi.nlm.nih.gov/pubmed/31305260
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI125015
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados